Quick Answer
OnKure Therapeutics, Inc. reported Shares Outstanding of 33.42 million shares for fiscal year 2023.
OnKure Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2023 | 33.42M | +35.3% |
| 2022 | 24.70M | +1.0% |
| 2021 | 24.46M | +1091.2% |
| 2020 | 2.05M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | 3.34M | -90.1% | -90.0% |
| June 30, 2024 | 33.42M | -1.1% | +0.0% |
| March 31, 2024 | 33.42M | +33.1% | +900.0% |
| December 31, 2023 | 3.34M | -86.5% | -90.1% |
| September 30, 2023 | 33.87M | +38.1% | +0.2% |
| June 30, 2023 | 33.80M | +38.1% | +34.6% |
| March 31, 2023 | 25.11M | +2.7% | +1.7% |
| December 31, 2022 | 24.70M | +1.0% | +0.7% |
- OnKure Therapeutics, Inc. showed an increase of +35.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2023 period, OnKure Therapeutics, Inc.’s shares outstanding has grown by 1527.8% (from 2.05 million shares to 33.42 million shares).
- The most recent figure is from OnKure Therapeutics, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: